Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NQO1 | P15559 | 4/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.65 |
| ▸ | LMNA | P02545 | 2/20 | 0.65 |
| ▸ | TSHR | P16473 | 2/20 | 0.65 |
| ▸ | MEN1 | O00255 | 1/20 | 0.65 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.65 |
| ▸ | TP53 | P04637 | 1/20 | 0.65 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.65 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.65 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.65 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.65 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.65 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.65 |
| ▸ | PCSK7 | Q16549 | 1/20 | 0.65 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.65 |
| ▸ | VKORC1 | Q9BQB6 | 1/20 | 0.59 |
| ▸ | HTT | P42858 | 1/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.58 |
| ▸ | NPC1 | O15118 | 2/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15851235 | 0.99 | ALDH1A1 (0.63) | NQO1ALDH1A1LMNATSHRMEN1 | |
| SCHEMBL15851237 | 0.99 | ALDH1A1 (0.63) | NQO1ALDH1A1LMNATSHRMEN1 | |
| SCHEMBL15851234 | 0.99 | ALDH1A1 (0.63) | NQO1ALDH1A1LMNATSHRMEN1 | |
| SCHEMBL15851241 | 0.99 | ALDH1A1 (0.63) | NQO1ALDH1A1LMNATSHRMEN1 | |
| SCHEMBL15851233 | 0.99 | ALDH1A1 (0.63) | NQO1ALDH1A1LMNATSHRMEN1 | |
| SCHEMBL15851240 | 0.99 | ALDH1A1 (0.63) | NQO1ALDH1A1LMNATSHRMEN1 | |
| SCHEMBL15851236 | 0.99 | ALDH1A1 (0.63) | NQO1ALDH1A1LMNATSHRMEN1 | |
| SCHEMBL15851238 | 0.99 | ALDH1A1 (0.63) | NQO1ALDH1A1LMNATSHRMEN1 | |
| SCHEMBL4530526 | 0.86 | SRC (0.52) | NQO1ALDH1A1LMNATSHRMEN1 | |
| SCHEMBL9210044 | 0.86 | NQO1 (0.58) | NQO1ALDH1A1LMNATSHRMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 115 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2699218-B1 | USE OF A COMBINATION OF CAROTENOID, PHYTOESTROGEN AND VITAMIN C FOR THE PREVENTION AND/OR TREATMENT OF PIGMENTATION DISORDERS | NUTRICOS TECH (FR) | 2018-10-17 | — | — | EP | claimed |
| EP-2900336-B1 | ORAL COMPOSITION FOR REINFORCING SKIN TOLERANCE FOLLOWING TOPICAL ADMINISTRATION OF A RETINOID COMPOUND | NUTRICOS TECH (FR) | 2018-07-25 | — | — | EP | claimed |
| US-10022315-B2 | Oral composition for reinforcing skin tolerance following topical administration of a retinoid compound | LABORATOIRES INNEOV (FR) | 2018-07-17 | — | — | US | claimed |
| US-20150258000-A1 | ORAL COMPOSITION FOR REINFORCING SKIN TOLERANCE FOLLOWING TOPICAL ADMINISTRATION OF A RETINOID COMPOUND | LABORATORIES INNEOV (FR) | 2015-09-17 | — | — | US | claimed |
| EP-2900336-A2 | ORAL COMPOSITION FOR REINFORCING SKIN TOLERANCE FOLLOWING TOPICAL ADMINISTRATION OF A RETINOID COMPOUND | Laboratoires Inneov (FR) | 2015-08-05 | — | — | EP | claimed |
| US-20140148401-A1 | COMBINATION OF CAROTENOID, PHYTOOESTROGEN AND VITAMIN C FOR MOISTURIZING THE SKIN | LABORATOIRES INNEOV (FR) | 2014-05-29 | — | — | US | claimed |
| EP-2699225-A1 | COMBINATION OF CAROTENOID, PHYTOOESTROGEN AND VITAMIN C FOR MOISTURIZING THE SKIN | Laboratoires Inneov SNC (FR) | 2014-02-26 | — | — | EP | claimed |
| EP-2699218-A1 | USE OF A COMBINATION OF CAROTENOID, PHYTOESTROGEN AND VITAMIN C FOR THE PREVENTION AND/OR TREATMENT OF PIGMENTATION DISORDERS | Laboratoires Inneov (FR) | 2014-02-26 | — | — | EP | claimed |
| WO-2012143856-A1 | USE OF A COMBINATION OF CAROTENOID, PHYTOESTROGEN AND VITAMIN C FOR THE PREVENTION AND/OR TREATMENT OF PIGMENTATION DISORDERS | LABORATOIRES INNEOV (FR) | 2012-10-26 | — | — | WO | claimed |
| WO-2012143857-A1 | COMBINATION OF CAROTENOID, PHYTOOESTROGEN AND VITAMIN C FOR MOISTURIZING THE SKIN | LABORATOIRES INNEOV (FR) | 2012-10-26 | — | — | WO | claimed |
| US-20100199370-A1 | MEANS AND METHODS OF PRODUCING FRUITS WITH HIGH LEVELS OF ANTHOCYANINS AND FLAVONOLS | The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research | 2010-08-05 | — | — | US | claimed |
| EP-2131646-A2 | MEANS AND METHODS OF PRODUCING FRUITS WITH HIGH LEVELS OF ANTHOCYANINS AND FLAVONOLS | The State of Israel, Ministry of Agriculture and Rural Development, Agricultural Research Organisation, Volcani Center (IL) | 2009-12-16 | — | — | EP | claimed |
| US-20090105330-A1 | ADMIXTURE OF CAROTENOIDS AND ISOFLAVONOIDS FOR TREATING CUTANEOUS SYMPTOMS OF AGING | L'OREAL (FR) | 2009-04-23 | — | — | US | claimed |
| WO-2008096354-A2 | MEANS AND METHODS OF PRODUCING FRUITS WITH HIGH LEVELS OF ANTHOCYANINS AND FLAVONOLS | THE STATE OF ISRAEL, MINISTRY OF AGRICULTURE & RURAL DEVELOPMENT, AGRICULTURAL RESEARCH ORGANIZATION, (A.R.O.), THE VOLCANL CENTER (IL) | 2008-08-14 | — | — | WO | claimed |
| US-20040071745-A1 | Admixture of carotenoids and isoflavonoids for treating cutaneous symptoms of aging | SOCIETE L'OREAL S.A. (FR) | 2004-04-15 | — | — | US | claimed |
| EP-1331925-A2 | USE OF AN ASSOCIATION OF AT LEAST A CAROTENOID AND OF AT LEAST AN ISOFLAVONOID FOR TREATING CUTANEOUS SYMPTOMS OF AGEING | L'OREAL (FR) | 2003-08-06 | — | — | EP | claimed |
| US-20020197289-A1 | Compositions and methods for combating the appearance of ageing | L'OREAL (FR) | 2002-12-26 | — | — | US | claimed |
| EP-1262168-A1 | Composition containing fibres to combat the skin aging process | L'OREAL (FR) | 2002-12-04 | — | — | EP | claimed |
| WO-2002034233-A2 | USE OF AN ASSOCIATION OF A CAROTENOID AND OF AN ISOFLAVONOID FOR TREATING CUTANEOUS SYMPTOMS OF AGEING | L'OREAL (FR) | 2002-05-02 | — | — | WO | claimed |
| US-11730682-B2 | Self-standing cosmetic sheet | L'OREAL (FR) | 2023-08-22 | — | — | US | disclosed |
| EP-2836187-B1 | SELF-STANDING COSMETIC SHEET | OREAL (FR) | 2021-12-08 | — | — | EP | disclosed |
| EP-2699218-B1 | USE OF A COMBINATION OF CAROTENOID, PHYTOESTROGEN AND VITAMIN C FOR THE PREVENTION AND/OR TREATMENT OF PIGMENTATION DISORDERS | NUTRICOS TECH (FR) | 2018-10-17 | — | — | EP | disclosed |
| US-20180235849-A1 | SELF-STANDING COSMETIC SHEET | L'OREAL (FR) | 2018-08-23 | — | — | US | disclosed |
| EP-2900336-B1 | ORAL COMPOSITION FOR REINFORCING SKIN TOLERANCE FOLLOWING TOPICAL ADMINISTRATION OF A RETINOID COMPOUND | NUTRICOS TECH (FR) | 2018-07-25 | — | — | EP | disclosed |
| US-10022315-B2 | Oral composition for reinforcing skin tolerance following topical administration of a retinoid compound | LABORATOIRES INNEOV (FR) | 2018-07-17 | — | — | US | disclosed |
| WO-2018115239-A1 | COMPOSITION COMPRISING HYDROXYETHYLPIPERAZINEETHANESULFONIC ACID AND AT LEAST ONE ALKYLPOLYGLUCOSIDE | L'OREAL (FR) | 2018-06-28 | — | — | WO | disclosed |
| US-9949897-B2 | Self-standing cosmetic sheet | L'OREAL (FR) | 2018-04-24 | — | — | US | disclosed |
| EP-2335683-B1 | Cosmetic kit formulation | L'ORÉAL (FR) | 2018-02-28 | — | — | EP | disclosed |
| EP-2910547-B1 | COMPOUND; TAUTOMER AND GEOMETRIC ISOMER THEREOF; SALT OF SAID COMPOUND, TAUTOMER, OR GEOMETRIC ISOMER; METHOD FOR MANUFACTURING SAID COMPOUND, TAUTOMER, ISOMER, OR SALT; ANTIMICROBIAL AGENT; AND ANTI-INFECTIVE DRUG | UNIV OKAYAMA (JP) | 2017-06-14 | — | — | EP | disclosed |
| US-9512075-B2 | Compound; tautomer and geometric isomer thereof; salt of said compound, tautomer, or geometric isomer; method for manufacturing said compound, tautomer, isomer, or salt; antimicrobial agent; and anti-infective drug | OKAYAMA UNIVERSITY (JP) | 2016-12-06 | — | — | US | disclosed |
| US-9512075-B2 | Compound; tautomer and geometric isomer thereof; salt of said compound, tautomer, or geometric isomer; method for manufacturing said compound, tautomer, isomer, or salt; antimicrobial agent; and anti-infective drug | OKAYAMA UNIVERSITY (JP) | 2016-12-06 | — | — | US | disclosed |
| US-20150291523-A1 | COMPOUND; TAUTOMER AND GEOMETRIC ISOMER THEREOF; SALT OF SAID COMPOUND, TAUTOMER, OR GEOMETRIC ISOMER; METHOD FOR MANUFACTURING SAID COMPOUND, TAUTOMER, ISOMER, OR SALT; ANTIMICROBIAL AGENT; AND ANTI-INFECTIVE DRUG | MICROBIAL CHEMISTRY RESEARCH FOUNDATION (JP) | 2015-10-15 | — | — | US | disclosed |
| US-20150291523-A1 | COMPOUND; TAUTOMER AND GEOMETRIC ISOMER THEREOF; SALT OF SAID COMPOUND, TAUTOMER, OR GEOMETRIC ISOMER; METHOD FOR MANUFACTURING SAID COMPOUND, TAUTOMER, ISOMER, OR SALT; ANTIMICROBIAL AGENT; AND ANTI-INFECTIVE DRUG | MICROBIAL CHEMISTRY RESEARCH FOUNDATION (JP) | 2015-10-15 | — | — | US | disclosed |
| US-20150258000-A1 | ORAL COMPOSITION FOR REINFORCING SKIN TOLERANCE FOLLOWING TOPICAL ADMINISTRATION OF A RETINOID COMPOUND | LABORATORIES INNEOV (FR) | 2015-09-17 | — | — | US | disclosed |
| EP-2910547-A1 | COMPOUND; TAUTOMER AND GEOMETRIC ISOMER THEREOF; SALT OF SAID COMPOUND, TAUTOMER, OR GEOMETRIC ISOMER; METHOD FOR MANUFACTURING SAID COMPOUND, TAUTOMER, ISOMER, OR SALT; ANTIMICROBIAL AGENT; AND ANTI-INFECTIVE DRUG | Okayama University (JP) | 2015-08-26 | — | — | EP | disclosed |
| EP-2900336-A2 | ORAL COMPOSITION FOR REINFORCING SKIN TOLERANCE FOLLOWING TOPICAL ADMINISTRATION OF A RETINOID COMPOUND | Laboratoires Inneov (FR) | 2015-08-05 | — | — | EP | disclosed |
| US-20150209243-A1 | SELF-STANDING COSMETIC SHEET | L'OREAL (FR) | 2015-07-30 | — | — | US | disclosed |
| EP-2836187-A1 | SELF-STANDING COSMETIC SHEET | L'Oréal (FR) | 2015-02-18 | — | — | EP | disclosed |
| US-20140148401-A1 | COMBINATION OF CAROTENOID, PHYTOOESTROGEN AND VITAMIN C FOR MOISTURIZING THE SKIN | LABORATOIRES INNEOV (FR) | 2014-05-29 | — | — | US | disclosed |
| EP-1807118-B1 | STEROID ANALOGS AND CHARACTERIZATION AND TREATMENT METHODS | HARBOR BIOSCIENCES INC (US) | 2014-03-12 | — | — | EP | disclosed |
| EP-2699225-A1 | COMBINATION OF CAROTENOID, PHYTOOESTROGEN AND VITAMIN C FOR MOISTURIZING THE SKIN | Laboratoires Inneov SNC (FR) | 2014-02-26 | — | — | EP | disclosed |
| EP-2699218-A1 | USE OF A COMBINATION OF CAROTENOID, PHYTOESTROGEN AND VITAMIN C FOR THE PREVENTION AND/OR TREATMENT OF PIGMENTATION DISORDERS | Laboratoires Inneov (FR) | 2014-02-26 | — | — | EP | disclosed |
| WO-2013153678-A1 | SELF-STANDING COSMETIC SHEET | L'OREAL (FR) | 2013-10-17 | — | — | WO | disclosed |
| WO-2012143856-A1 | USE OF A COMBINATION OF CAROTENOID, PHYTOESTROGEN AND VITAMIN C FOR THE PREVENTION AND/OR TREATMENT OF PIGMENTATION DISORDERS | LABORATOIRES INNEOV (FR) | 2012-10-26 | — | — | WO | disclosed |
| WO-2012143857-A1 | COMBINATION OF CAROTENOID, PHYTOOESTROGEN AND VITAMIN C FOR MOISTURIZING THE SKIN | LABORATOIRES INNEOV (FR) | 2012-10-26 | — | — | WO | disclosed |
| EP-2471536-A1 | STEROID ANALOGS AND CHARACTERIZATION AND TREATMENT METHODS | Harbor BioSciences, Inc. (US) | 2012-07-04 | — | — | EP | disclosed |
| CN-101817830-B | Method for synthesizing Coumestan derivatives | UNIV TIANJIN | 2011-09-28 | — | — | CN | disclosed |
| EP-2335683-A1 | Cosmetic kit formulation | L'Oréal (FR) | 2011-06-22 | — | — | EP | disclosed |
| CN-101817830-A | Method for synthesizing Coumestan derivatives | UNIV TIANJIN | 2010-09-01 | — | — | CN | disclosed |
| US-20100199370-A1 | MEANS AND METHODS OF PRODUCING FRUITS WITH HIGH LEVELS OF ANTHOCYANINS AND FLAVONOLS | The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research | 2010-08-05 | — | — | US | disclosed |
| US-20090324663-A1 | KIT FOR FORMULATING A COSMETIC PRODUCT | L'OREAL (FR) | 2009-12-31 | — | — | US | disclosed |
| EP-2131646-A2 | MEANS AND METHODS OF PRODUCING FRUITS WITH HIGH LEVELS OF ANTHOCYANINS AND FLAVONOLS | The State of Israel, Ministry of Agriculture and Rural Development, Agricultural Research Organisation, Volcani Center (IL) | 2009-12-16 | — | — | EP | disclosed |
| US-20090105330-A1 | ADMIXTURE OF CAROTENOIDS AND ISOFLAVONOIDS FOR TREATING CUTANEOUS SYMPTOMS OF AGING | L'OREAL (FR) | 2009-04-23 | — | — | US | disclosed |
| US-7481845-B2 | Composition for protecting keratin material, process of making, uses thereof | L'OREAL (FR) | 2009-01-27 | — | — | US | disclosed |
| WO-2008117291-A1 | SYSTEM AND METHOD FOR MINEFIELD IDENTIFICATION | BUZAGLO YORESH AVI (IL) | 2008-10-02 | — | — | WO | disclosed |
| WO-2008096354-A2 | MEANS AND METHODS OF PRODUCING FRUITS WITH HIGH LEVELS OF ANTHOCYANINS AND FLAVONOLS | THE STATE OF ISRAEL, MINISTRY OF AGRICULTURE & RURAL DEVELOPMENT, AGRICULTURAL RESEARCH ORGANIZATION, (A.R.O.), THE VOLCANL CENTER (IL) | 2008-08-14 | — | — | WO | disclosed |
| US-20080081055-A1 | FILM WITH IMPROVED DISSOLUTION, COSMETIC PRODUCT | L'OREAL (FR) | 2008-04-03 | — | — | US | disclosed |
| EP-1555984-B1 | PROCESS FOR DISSOLVING LIPOPHILIC COMPOUNDS, AND COSMETIC COMPOSITION. | OREAL (FR) | 2008-03-12 | — | — | EP | disclosed |
| EP-1892015-A2 | Film showing an improved solubility and cosmetic product comprising said film | L'Oréal (FR) | 2008-02-27 | — | — | EP | disclosed |
| US-7323621-B2 | Method of decreasing liquiritigenin-derived isoflavones relative to total isoflavones in plants and plants producing reduced ratio of liquiritigenin-derived isoflavones relative to total isoflavones | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2008-01-29 | — | — | US | disclosed |
| EP-1807118-A2 | STEROID ANALOGS AND CHARACTERIZATION AND TREATMENT METHODS | Hollis-Eden Pharmaceuticals Inc. (US) | 2007-07-18 | — | — | EP | disclosed |
| EP-1588694-B1 | Cosmetic product formulation kit | OREAL (FR) | 2007-05-23 | — | — | EP | disclosed |
| US-7189895-B2 | Methods to increase the isoflavonoid levels in plants and plants producing increased levels of isoflavonoids | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-03-13 | — | — | US | disclosed |
| US-20070014719-A1 | Steroid analogs and characterization and treatment methods | BIOVIE INC. | 2007-01-18 | — | — | US | disclosed |
| EP-1343459-B1 | COMPOSITION, IN PARTICULAR COSMETIC, CONTAINING 7-HYDROXY DHEA AND/OR 7-KETO DHEA AND AT LEAST ONE ISOFLAVONOID | OREAL (FR) | 2007-01-03 | — | — | EP | disclosed |
| US-20060242735-A1 | Nucleic acid fragments encoding isoflavone synthase | FADER GARY M | 2006-10-26 | — | — | US | disclosed |
| WO-2006110172-A2 | STEROID ANALOGS AND CHARACTERIZATION AND TREATMENT METHODS | HOLLIS-EDEN PHARMACEUTICALS.INC. (US) | 2006-10-19 | — | — | WO | disclosed |
| US-20060218672-A1 | Method for altering the isoflavonoid profile in the plant parts of an isoflavonoid-producing plant | ODELL JOAN T | 2006-09-28 | — | — | US | disclosed |
| US-7098011-B1 | Nucleic acid sequences encoding isoflavone synthase | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2006-08-29 | — | — | US | disclosed |
| EP-1243252-B1 | Skin composition containing fibres and ubiquinones | OREAL (FR) | 2006-05-24 | — | — | EP | disclosed |
| US-20060035846-A1 | Preventing/correcting functional disorders of the pilosebaceous unit of mammals | L'OREAL (FR) | 2006-02-16 | — | — | US | disclosed |
| US-20060024337-A1 | Process for dissolving lipophilic compounds in aqueous solution with amphiphilic block copolymers, and cosmetic composition | L'OREAL (FR) | 2006-02-02 | — | — | US | disclosed |
| EP-1616551-A1 | Cosmetic treatment for preventing or delaying the signs of skin ageing | L'OREAL (FR) | 2006-01-18 | — | — | EP | disclosed |
| US-20060005276-A1 | Transgenic soybean seeds having reduced activity of lipoxygenases | E. I. DU PONT DE NEMOURS AND COMPANY | 2006-01-05 | — | — | US | disclosed |
| US-20050249763-A1 | Kit for formulating a cosmetic product | L'OREAL (FR) | 2005-11-10 | — | — | US | disclosed |
| EP-1588694-A1 | Cosmetic product formulation kit | L'OREAL (FR) | 2005-10-26 | — | — | EP | disclosed |
| WO-2005089198-A2 | TRANSGENIC SOYBEAN SEEDS HAVING REDUCED ACTIVITY OF LIPOXYGENASES | E.I. DUPONT DE NEMOURS AND COMPANY (US) | 2005-09-29 | — | — | WO | disclosed |
| US-20050166336-A1 | Composition for protecting keratin material, process of making, uses thereof | L'OREAL (FR) | 2005-08-04 | — | — | US | disclosed |
| EP-1559414-A1 | Use of a composition obtained from a pressurised fluid and protecting agents for the protection of keratinous fibers | L'OREAL (FR) | 2005-08-03 | — | — | EP | disclosed |
| EP-1555984-A2 | PROCESS FOR DISSOLVING LIPOPHILIC COMPOUNDS, AND COSMETIC COMPOSITION. | L'OREAL (FR) | 2005-07-27 | — | — | EP | disclosed |
| EP-1553851-A2 | COSMETIC COMPOSITION FOR PREVENTING AND/OR CORRECTING THE FUNCTIONAL DISORDERS OF THE PILO-SEBACEOUS UNIT OF MAMMALS | L'OREAL (FR) | 2005-07-20 | — | — | EP | disclosed |
| US-6906106-B2 | Compositions for the skin comprising fibers and ubiquinones and methods of using the same | L'OREAL (FR) | 2005-06-14 | — | — | US | disclosed |
| EP-1401260-A4 | A METHOD FOR ALTERING THE ISOFLAVONOID PROFILE IN THE PLANT PARTS OF AN ISOFLAVONOID-PRODUCING PLANT | DU PONT (US) | 2005-04-06 | — | — | EP | disclosed |
| US-6852326-B2 | Composition, in particular cosmetic, containing 7-hydroxy DHEA and/or 7-keto DHEA and at least an isoflavonoid | L'OREAL (FR) | 2005-02-08 | — | — | US | disclosed |
| US-20040128714-A1 | Method of decreasing liquiritigenin-derived isoflavones relative to total isoflavones in plants and plants producing reduced ratio of liquiritigenin-derived isoflavones relative to total isoflavones | E.I. DU PONT DE NEMOURS AND COMPANY | 2004-07-01 | — | — | US | disclosed |
| WO-2004035013-A2 | PROCESS FOR DISSOLVING LIPOPHILIC COMPOUNDS, AND COSMETIC COMPOSITION | L'OREAL (FR) | 2004-04-29 | — | — | WO | disclosed |
| WO-2004034820-A2 | COSMETIC COMPOSITION FOR PREVENTING AND/OR CORRECTING THE FUNCTIONAL DISORDERS OF THE PILO-SEBACEOUS UNIT OF MAMMALS | L'OREAL (FR) | 2004-04-29 | — | — | WO | disclosed |
| US-20040072764-A1 | Composition, in particular cosmetic, containing 7-hydroxy dhea and/or 7-keto dhea and at least an isoflavonoid | L'OREAL (FR) | 2004-04-15 | — | — | US | disclosed |
| US-20040071745-A1 | Admixture of carotenoids and isoflavonoids for treating cutaneous symptoms of aging | SOCIETE L'OREAL S.A. (FR) | 2004-04-15 | — | — | US | disclosed |
| EP-1401260-A2 | A METHOD FOR ALTERING THE ISOFLAVONOID PROFILE IN THE PLANT PARTS OF AN ISOFLAVONOID-PRODUCING PLANT | E.I. du Pont de Nemours and Company (US) | 2004-03-31 | — | — | EP | disclosed |
| US-20040006795-A1 | Methods to increase the isoflavonoid levels in plants and plants producing increased levels of isoflavonoids | E. I. DU PONT DE NEMOURS AND COMPANY | 2004-01-08 | — | — | US | disclosed |
| WO-2003106633-A2 | METHOD TO INCREASE ISOFLAVONOID LEVELS IN PLANTS AND PLANTS PRODUCING INCREASED LEVELS OF ISOFLAVONOIDS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2003-12-24 | — | — | WO | disclosed |
| US-20030150012-A1 | Method for altering the isoflavonoid profile in the plant parts of an isoflavonoid-producing plant | E. I. DU PONT DE NEMOURS AND COMPANY | 2003-08-07 | — | — | US | disclosed |
| EP-1331925-A2 | USE OF AN ASSOCIATION OF AT LEAST A CAROTENOID AND OF AT LEAST AN ISOFLAVONOID FOR TREATING CUTANEOUS SYMPTOMS OF AGEING | L'OREAL (FR) | 2003-08-06 | — | — | EP | disclosed |
| EP-1303250-A1 | COMPOSITION, IN PARTICULAR COSMETIC, CONTAINING DHEA AND ISOFLAVONOID | L'OREAL (FR) | 2003-04-23 | — | — | EP | disclosed |
| WO-2003013466-A1 | COMPOSITION COMPRISING AN ASSOCIATION OF IGF1 AND AT LEAST ONE ISOFLAVONOID | L'OREAL (FR) | 2003-02-20 | — | — | WO | disclosed |
| WO-2002101023-A9 | A METHOD FOR ALTERING THE ISOFLAVONOID PROFILE IN THE PLANT PARTS OF AN ISOFLAVONOID-PRODUCING PLANT | DU PONT (US) | 2003-02-06 | — | — | WO | disclosed |
| US-20020197288-A1 | Compositions for the skin comprising fibers and ubiquinones and methods of using the same | L'OREAL (FR) | 2002-12-26 | — | — | US | disclosed |
| US-20020197289-A1 | Compositions and methods for combating the appearance of ageing | L'OREAL (FR) | 2002-12-26 | — | — | US | disclosed |
| WO-2002101023-A2 | A METHOD FOR ALTERING THE ISOFLAVONOID PROFILE IN THE PLANT PARTS OF AN ISOFLAVONOID-PRODUCING PLANT | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2002-12-19 | — | — | WO | disclosed |
| EP-1262168-A1 | Composition containing fibres to combat the skin aging process | L'OREAL (FR) | 2002-12-04 | — | — | EP | disclosed |
| US-20020142017-A1 | Suspension of nanospheres of lipophilic active principle stabilized with water-dispersible polymers | L'OREAL (FR) | 2002-10-03 | — | — | US | disclosed |
| EP-1245222-A2 | Topical composition containing fibres and enzymes | L'OREAL (FR) | 2002-10-02 | — | — | EP | disclosed |
| EP-1243253-A1 | Composition containing fibres and steroids | L'OREAL (FR) | 2002-09-25 | — | — | EP | disclosed |
| EP-1243252-A1 | Skin composition containing fibres and ubiquinones | L'OREAL (FR) | 2002-09-25 | — | — | EP | disclosed |
| EP-1243254-A1 | Composition containing fibres and a flavonoid | L'OREAL (FR) | 2002-09-25 | — | — | EP | disclosed |
| US-20020107282-A1 | Cosmetic composition containing an aminophenol derivative and an isoflavonoid | L'OREAL (FR) | 2002-08-08 | — | — | US | disclosed |
| EP-1228746-A1 | Suspension of nanospheres of lipophilic active ingredients stabilised with water-dispersible polymers | L'OREAL (FR) | 2002-08-07 | — | — | EP | disclosed |
| EP-1205179-A1 | Cosmetic composition comprising an aminophenol derivative and an isoflavonoid | L'OREAL (FR) | 2002-05-15 | — | — | EP | disclosed |
| WO-2002034233-A2 | USE OF AN ASSOCIATION OF A CAROTENOID AND OF AN ISOFLAVONOID FOR TREATING CUTANEOUS SYMPTOMS OF AGEING | L'OREAL (FR) | 2002-05-02 | — | — | WO | disclosed |
| WO-2002005764-A1 | COMPOSITION, IN PARTICULAR COSMETIC, CONTAINING DHEA AND ISOFLAVONOID | L'OREAL (FR) | 2002-01-24 | — | — | WO | disclosed |
| EP-1147199-A1 | NUCLEIC ACID SEQUENCES ENCODING ISOFLAVONE SYNTHASE | E.I. DUPONT DE NEMOURS AND COMPANY (US) | 2001-10-24 | — | — | EP | disclosed |
| WO-2000044909-A1 | NUCLEIC ACID SEQUENCES ENCODING ISOFLAVONE SYNTHASE | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2000-08-03 | — | — | WO | disclosed |
| US-5585357-A | Heteroaryloxymethyl ketones as interleukin-1βconverting enzyme inhibitors | SANOFI WINTHROP INC. (US) | 1996-12-17 | — | — | US | disclosed |
| EP-0644198-A1 | Alpha-heteroaryloxymethyl ketones as interleukin-1beta converting enzyme inhibitors | STERLING WINTHROP INC. (US) | 1995-03-22 | — | — | EP | disclosed |
| EP-0644198-A1 | Alpha-heteroaryloxymethyl ketones as interleukin-1beta converting enzyme inhibitors | STERLING WINTHROP INC. (US) | 1995-03-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (13 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020107282-A1 | Cosmetic composition containing an aminophenol derivative and an isoflavonoid | TYR, CYP19A1, EYA3 | NQO1 58/4885ALDH1A1 1694/4885LMNA 2340/4885 |
| US-20050249763-A1 | Kit for formulating a cosmetic product | KIT, CUTA, MITF | NQO1 1310/4885ALDH1A1 377/4885LMNA 1384/4885 |
| US-20090324663-A1 | KIT FOR FORMULATING A COSMETIC PRODUCT | KIT, CUTA, MITF | NQO1 1310/4885ALDH1A1 377/4885LMNA 1384/4885 |
| US-20020197289-A1 | Compositions and methods for combating the appearance of ageing | CYP24A1, CYP27B1, CYP2R1 | NQO1 68/4885ALDH1A1 1440/4885LMNA 970/4885 |
| US-20020142017-A1 | Suspension of nanospheres of lipophilic active principle stabilized with water-dispersible polymers | LIPA, S100P, LSS | NQO1 858/4885ALDH1A1 1344/4885LMNA 1015/4885 |
| US-20070014719-A1 | Steroid analogs and characterization and treatment methods | CYP17A1, HSD17B11, HSD3B1 | NQO1 678/4885ALDH1A1 603/4885LMNA 2328/4885 |
| US-20150209243-A1 | SELF-STANDING COSMETIC SHEET | CUTA, SUCLG1, SIGLEC7 | NQO1 2544/4885ALDH1A1 423/4885LMNA 1035/4885 |
| US-20080081055-A1 | FILM WITH IMPROVED DISSOLUTION, COSMETIC PRODUCT | PUF60, TREH, CUTA | NQO1 4577/4885ALDH1A1 871/4885LMNA 3255/4885 |
| US-20150291523-A1 | COMPOUND; TAUTOMER AND GEOMETRIC ISOMER THEREOF; SALT OF SAID COMPOUND, TAUTOMER, OR GEOMETRIC ISOMER; METHOD FOR MANUFACTURING SAID COMPOUND, TAUTOMER, ISOMER, OR SALT; ANTIMICROBIAL AGENT; AND ANTI-INFECTIVE DRUG | FURIN, ACE, SHARPIN | NQO1 42/4885ALDH1A1 1348/4885LMNA 1262/4885 |
| US-20180235849-A1 | SELF-STANDING COSMETIC SHEET | CUTA, DSG1, SUCLG1 | NQO1 2646/4885ALDH1A1 981/4885LMNA 2074/4885 |
| US-20060024337-A1 | Process for dissolving lipophilic compounds in aqueous solution with amphiphilic block copolymers, and cosmetic composition | LIPA, ABCB4, MGLL | NQO1 4247/4885ALDH1A1 3104/4885LMNA 704/4885 |
| US-11730682-B2 | Self-standing cosmetic sheet | CUTA, DSG1, SUCLG1 | NQO1 2646/4885ALDH1A1 981/4885LMNA 2074/4885 |
| US-20050166336-A1 | Composition for protecting keratin material, process of making, uses thereof | KRT18, CKAP4, KLK5 | NQO1 2921/4885ALDH1A1 3962/4885LMNA 254/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.